Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Acta Otorrinolaringol Esp (Engl Ed) ; 71(6): 386-392, 2020.
Artículo en Español | MEDLINE | ID: covidwho-1002943

RESUMEN

The current COVID-19 pandemic has rendered up to 15% of patients under mechanical ventilation. Because the subsequent tracheotomy is a frequent procedure, the three societies mostly involved (SEMICYUC, SEDAR and SEORL-CCC) have setup a consensus paper that offers an overview about indications and contraindications of tracheotomy, be it by puncture or open, clarifying its respective advantages and enumerating the ideal conditions under which they should be performed, as well as the necessary steps. Regular and emergency situations are displayed together with the postoperative measures.


Asunto(s)
Betacoronavirus , Consenso , Infecciones por Coronavirus/epidemiología , Neumonía Viral/epidemiología , Sociedades Médicas , Traqueostomía/normas , Anestesiología , Broncoscopía/efectos adversos , Broncoscopía/normas , COVID-19 , Contraindicaciones de los Procedimientos , Unidades de Cuidados Coronarios , Procedimientos Quirúrgicos Electivos/normas , Urgencias Médicas , Humanos , Unidades de Cuidados Intensivos , Otolaringología , Procedimientos Quirúrgicos Otorrinolaringológicos , Pandemias , Cuidados Posoperatorios/métodos , Cuidados Posoperatorios/normas , Respiración Artificial/normas , Resucitación , SARS-CoV-2 , España , Factores de Tiempo , Traqueostomía/efectos adversos , Traqueostomía/métodos
2.
Arch Bronconeumol ; 56: 11-18, 2020 Jul.
Artículo en Español | MEDLINE | ID: covidwho-699748

RESUMEN

Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure.This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.

3.
Med Intensiva (Engl Ed) ; 44(7): 429-438, 2020 Oct.
Artículo en Inglés, Español | MEDLINE | ID: covidwho-19657

RESUMEN

Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/complicaciones , Ventilación no Invasiva/métodos , Pandemias , Neumonía Viral/complicaciones , Insuficiencia Respiratoria/terapia , Enfermedad Aguda , Adulto , Aerosoles , COVID-19 , Infecciones por Coronavirus/prevención & control , Infecciones por Coronavirus/terapia , Infección Hospitalaria/prevención & control , Manejo de la Enfermedad , Contaminación de Equipos , Diseño de Equipo , Humanos , Transmisión de Enfermedad Infecciosa de Paciente a Profesional/prevención & control , Transmisión de Enfermedad Infecciosa de Profesional a Paciente/prevención & control , Ventilación no Invasiva/instrumentación , Ventilación no Invasiva/normas , Terapia por Inhalación de Oxígeno/instrumentación , Terapia por Inhalación de Oxígeno/métodos , Pandemias/prevención & control , Neumonía Viral/prevención & control , Neumonía Viral/terapia , Síndrome de Dificultad Respiratoria/etiología , Síndrome de Dificultad Respiratoria/terapia , Insuficiencia Respiratoria/etiología , SARS-CoV-2
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA